Biocon Ltd.
Snapshot View

View in App

Prices View details >>

235.50 +0.20 ▲0.1%

27 January 2023, 04:01:00 PM
Volume: 258,706

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biocon.com
Market Cap 28,274.13 Cr.
Enterprise Value(EV) 32,412.03 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 5.14 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 45.83 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 80.18 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.94 Calculated using Price: 235.50
Dividend Yield 0.21 Period Ending 2022-03
No. of Shares Subscribed 120.06 Cr. 1,200,600,000 Shares
FaceValue 5
Company Profile
The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.08%
1 Week
-3.88%
1 Month
-11.30%
3 Month
-14.72%
6 Month
-27.04%
1 Year
-34.56%
2 Year
-37.63%
5 Year
-22.44%
10 Year
+428.03%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 17.22 16.31 15.37 8.74 18.00 14.26 13.16 12.47
Return on Capital Employed (%) 15.75 15.30 13.93 12.59 8.92 16.11 14.35 11.30 9.93
Return on Assets (%) 8.47 8.72 7.96 7.64 4.55 9.25 6.94 5.73 5.11

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3,027 3,271 4,034 4,838 5,181 6,098 6,706 7,627 8,433 9,628
Non Curr. Liab. 1,262 1,378 2,421 2,305 2,007 2,122 2,685 5,497 6,803 7,394
Curr. Liab. 1,380 1,555 1,666 1,678 2,141 3,039 4,008 4,210 3,828 4,125
Minority Int. 82 172 266 376 468 609 677 881 1,038 1,212
Equity & Liab. 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 22,359
Non Curr. Assets 3,112 3,813 4,416 5,149 5,648 6,979 8,751 10,614 11,718 12,311
Curr. Assets 2,639 2,563 3,971 4,048 4,149 4,889 5,325 7,600 8,382 10,048
Misc. Exp. not W/O
Total Assets 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 22,359

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 2,877 3,090 3,347 3,891 4,123 5,514 6,301 7,143 8,184 9,042
Other Income 56 53 84 157 206 414 508 605 689 258
Total Income 2,933 3,143 3,431 4,048 4,330 5,929 6,808 7,748 8,873 9,300
Total Expenditure -2,190 -2,394 -2,584 -2,912 -3,294 -4,391 -5,044 -5,841 -6,690 -7,092
PBIDT 743 749 847 1,137 1,035 1,538 1,765 1,907 2,183 2,208
Interest -2 -9 -29 -26 -62 -71 -65 -58 -68 -75
Depreciation -204 -221 -249 -277 -385 -448 -552 -715 -814 -866
Taxation -107 -96 -142 -162 -157 -212 -315 -222 -212 -285
Exceptional Items 105 161 195 68 13 -111 -58
PAT 431 528 587 672 432 1,002 900 926 979 924
Minority Interest -17 -31 -59 -76 -81 -97 -123 -106 -123 -136
Share Associate 22 16 21 1 -29 -79 -207 -172
Other Related Items
Consolidated Net Profit 414 497 550 612 372 905 748 741 648 617
Adjusted EPS 3 4 5 5 3 8 6 6 5 5

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 471 561 211 371 640 662 1,155 1,283 1,160 1,177
Cash Fr. Inv. -376 -938 -509 -1,142 -499 -684 -714 -1,559 -3,625 -1,699
Cash Fr. Finan. -9 426 186 1,068 -178 -240 -242 388 2,564 242
Net Change 87 49 -112 297 -36 -262 199 112 99 -280
Cash & Cash Eqvt 474 557 463 758 710 449 659 825 897 654

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 60.67 60.67 60.64 60.64 60.64 60.64 60.64 60.64 60.64
Public 39.33 39.33 39.36 39.36 39.36 39.36 39.36 39.36 39.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 24 Jan 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release titled Biocon Foundation Wins the Prestigious IHW Gold Award for Diseases Screening Initiative of the Year for 2022.The above information will also be available on the website of the Company at www.biocon.com.
Mon, 23 Jan 2023
Voting Results And Scrutinizers Report On Postal Ballot
In Continuation to our letter dated December 20 2022 seeking approval of the members by way of Postal Ballot through the remote e-voting process on the resolutions as set out in the Postal Ballot Notice dated December 19 2022 please find enclosed:1. Voting results pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulation) enclosed and marked as Annexure-1;2. Scrutinizers Report dated January 23 2023 pursuant to Section 110 of the Companies Act 2013 read with Rule 22 of the Companies (Management and Administration) Rules 2014 enclosed and marked as Annexure-2.
Mon, 16 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
This is to certify that the details of securities dematerialized and rematerialized during the quarter ended December 31 2022 as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of Biocon Limited are listed.The certificate from our RTA i.e. M/s. KFin Technologies Limited (Formerly known as KFin Technologies Private Limited) dated January 4 2023 confirming the above is enclosed for your reference.

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Biocon Ltd.

What is Biocon share price?
Can I buy Biocon shares now?
What is the Dividend Yield of Biocon?
What is the Market Cap of Biocon?
What are the key metrics to analyse Biocon?
What is the 52 Week High and Low of Biocon?
What is the trend of Biocon share price?